A recent study by the University of Turku and the University of Helsinki in Finland and the Finnish Social Insurance Institution Kela reveals that the average duration of ADHD medication for children ...

Moleculin Biotech's Q1 2025 earnings call highlights Phase 3 MIRACLE trial progress, EU regulatory signoff, patient enrollment milestones, and funding needs.

Experts say the European Vulnerability Database, or EUVD, should be a good resource, but only if ENISA manages to maintain it properly.

Some U.S. biotech companies are considering moving early-stage trials of new medicines outside the United States as worry ...

Cytokinetics' PDUFA date for aficamten was extended to December 26th of 2025, due to the FDA's need to review a submitted ...

The European Medicines Agency (EMA) has approved Moleculin Biotech’s clinical trial application (CTA) for a pivotal, ...

An EU committee is recommending that tranilast, the active ingredient in a pulmonary fibrosis drug candidate, be awarded ...

The European drugs regulator said on Thursday its safety panel has confirmed suicidal thoughts as a side effect of ...

The EMA has recommended extensions to the marketing authorizations for Adcetris, used to treat Hodgkin lymphoma, and ...

The Buffalo Bills left the door open for veteran wide receiver Amari Cooper to return in free agency, but his former team may beat them to it. Cooper had an uneven stint in Buffalo after joining ...

But it doesn’t take a SpaceX-level engineer to understand that the Office of Government Ethics — an agency few Americans know by name, but whose unchecked power casts a long shadow over our ...